SELECT (Follow-up) Evaluation of cardiovascular outcomes with semaglutide in patients with overweight or obesity and prior MI/stroke Medicine semaglutide Population ASCVD Phase III Starting year 2018 More information Clinicaltrials.gov Director of Study dr. F.M.A.C. Martens (Cardioloog) Deventer, Deventer Ziekenhuis
